Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2016

Oct 12, 2016

34807_dirs_2016-10-11_5d3dde33-51d8-4502-812a-14fa5ca3d7a0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2016-10-06

Reporting Person: Thomae Mya (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-06 Stock Option (Right to Buy) $0.262 A 5000 Acquired 2026-10-06 Common Stock (5000) Direct